Emotional Prosody Recognition in Autism Spectrum Disorder Without Intellectual Disability: A Systematic Review and Meta-Analysis.

J Autism Dev DisordApr 14, 2025 (epub)
Clinical ResearchPsychiatryOpen access

Qiyun Luo, Xiaoyan Zeng, Fei Chen et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined emotional prosody recognition in people with autism spectrum disorder without intellectual disability (ASD-without-ID), compared with typically developing participants. Across 29 eligible studies, a random-effects analysis found a moderate-to-large pooled difference (Hedges' g = -0.65), which remained stable after adjustment for publication bias using the trim-and-fill method. Emotional complexity and participant age significantly moderated variation in study effects. Differences were moderate for recognition of basic emotions and more pronounced for complex emotions, supporting further study of developmental and other factors.

Key findings

  • Across 29 studies, the pooled effect was Hedges' g = -0.65 and remained stable after trim-and-fill adjustment for publication bias.
  • Emotional complexity and participant age significantly moderated heterogeneity in effect sizes.
  • Differences in prosody recognition were moderate for basic emotions and more pronounced for complex emotions.

Why it matters

Recognising emotion from vocal tone is relevant to social interaction, and the pooled findings suggest this ability differs between ASD-without-ID and typically developing groups. The stronger differences reported for complex emotions, alongside age-related moderation, indicate that performance may vary with emotional and developmental demands. These findings help frame assessment and research questions without establishing individual-level impairment or its cause.

What to keep in mind

The meta-analysis combines studies with heterogeneous results and methods; emotional complexity and age accounted for some, but not all, variation. The abstract also identifies further investigation of IQ measures and speakers of tonal languages as needed.

Source

Published in J Autism Dev Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.